Efficacy and safety of house dust mite sublingual immunotherapy in preschool children with allergic rhinitis

Efficacy and safety of house dust mite sublingual immunotherapy in preschool children with allergic rhinitis - Efficacy and safety of house dust mite sublingual immunotherapy in preschool children with allergic rhinitis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039939

Enrollment

Registered

2020-03-25

Start date

2020-03-25

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perennial allergic rhinitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patient with allergic rhinitis, who have specific IgE RAST score 1 for Dermatophagoides pteronyssinus. 2)Patient who have perennial allergic rhinitis symptoms.

Exclusion criteria

Exclusion criteria: 1) Patients who have received immunotherapy. 2) Uncontrolled asthma patients. 3) Patients who were judged to be unsuitable for patient enrollment by their doctor.

Design outcomes

Primary

Measure	Time frame
Improvement rate of nasal and eye symptom scores after a year	—

Secondary

Measure	Time frame
Improvement rate of Medication scores after a year Frequency of adverse reaction Change of parameters in blood Sensitization of other inhaled antigens	—

Countries

Japan

Contacts

Public ContactKoki Sasamoto

National Sagamihara Hospital Pediatrics

kohki_sasamoto_0131@yahoo.co.jp042-742-8311

Outcome results